REFERENCES
- Besag F. M., Berry D. Interactions between antiepileptic and antipsychotic drugs. Drug Saf. 2006; 29: 95–118
- Clause D., Decleire P., Vanbinst R., Soyer A., Hantson P. Pharmacokinetic interaction between valproic acid and meropenem. Intens. Care Med. 2005; 31: 1293–1294
- Coves Orts F. J., Borras-Blasco J., Navarro-Ruiz A., Murcia-Lopez A., Palacios-Ortega F. Acute seizures due to a probable interaction between valproic acid and meropenem. Ann. Pharmacotherapy 2005; 39: 533–537
- De Turck B. J. G., Diltoer M. W., Cornelis P. J. W. W., Maes V., Spapen H. D. M., Camu F., Huyghens L. P. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J. Antimicrob. Chemother. 1998; 42: 563–564
- Fudio S., Carcas A., Pinana E., Ortega R. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. J. Clin. Pharm. Ther. 2006; 31: 393–396
- Horiuchi M., Kimura M., Tokumura M., Hasebe N., Arai T., Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics. Toxicology 2006; 222: 114–124
- Kanou M., Saeki K., Kato T., Takahashi K., Mizutani T. Study of in vitro glucuronidation of hydroxyquinolines with bovine liver microsomes. Fund. Clin. Pharmacol. 2002; 16: 513–517
- Kojima S., Nadai M., Kitaichi K., Wang L. I., Nabeshima T., Hasegawa T. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats. Antimicrob. Agents Chemother. 1998; 42: 3136–3140
- Llinares F., Bosacoma N., Hernandez C., Climent E., Selva J., Ordovas J. P. Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics. A discussion of three cases. Farmacia Hospitalaria 2003; 27: 258–263
- Mallet L., Babin S., Morais J. A. Valproic acid-induced hyperammonia and thrombocytopenia in an elderly woman. Ann. Pharmacother. 2004; 38: 1643–1647
- Mizutani T. PM frequencies of major CYPs in asians and caucasians. Drug Metab. Rev. 2003; 35: 99–106
- Mizutani T., Hattori A. New horizon of MDR1 (P-glycoprotein) study. Drug Metab. Rev. 2005; 37: 489–510
- Nacarkucuk E., Saglam H., Okan M. Meropenem decreases serum level of valproic acid. Pediatric Neurol. 2004; 31: 232–234
- Nagai K., Shimizu T., Togo A., Takeya M., Yokomizo Y., Sakata Y., Matsuishi T., Kato H. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. J. Antimicrob. Chemother. 1997; 39: 295–296
- Nakajima Y., Mizobuchi M., Nakamura M., Takagi H., Inagaki H., Kominami G., Koike M., Yamaguchi T. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats. Drug Metab. Dispos. 2004; 32: 1383–1391
- Negishi M., Pedersen L. G., Petrotchenko E., Shevtsov S., Gotokhov A., Kakuta Y., Pedersen L. C. Structure and function of sulfotransferases. Arch. Biochem. Biophys. 2001; 390: 149–157
- Ogawa K., Yumoto R., Hamada N., Nagai J., Takano M. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes. Epilepsy Res. 2006; 71: 76–87
- Omoda K., Murakami T., Yumoto R., Nagai J., Maeda Y., Kiribayashi Y., Takano M. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. J. Pharm. Sci. 2005; 94: 1685–1693
- Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br. J. Clin. Pharmacol. 2006; 61: 246–255
- Radomynska-Pandya A., Czernik P. J., Little J. M., Battaglia E., Mackenzie P.I. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev. 1999; 31: 817–899
- Remmer H., Schoene B., Fleischmann R. A. Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab. Dispos. 1973; 1: 224–230
- Sala F., Padulles N., Hidalgo F., Clemente S., Cabanas M. J., Oliveras M., Balcells J. Pharmacokinetic interaction between valproic acid and meropenem. An Pediatr (Barc) 2006; 64: 93–95
- Santucci M., Parmeggiani A., Riva R. Seizure worsening caused by decreased serum valproate during meropenem therapy. J. Child Neur. 2005; 20: 456–457
- Torii M., Takiguchi Y., Saito F., Izumi M., Yokota M. Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats. J. Pharm. Pharmacol. 2001; 53: 823–829
- Torii M., Takiguchi Y., Izumi M., Fukushima T., Yokota M. Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers. Int. J. Pharm. 2002; 233: 253–256
- Usui T., Kuno T., Ueyama H., Ohkubo I., Mizutani T. Proximal HNF1 element is essential for the induction of human UDP-glucoronosyltransferase 1A1 by glucocorticoid receptor. Biochem. Pharmacol. 2006; 71: 693–701
- Yamagata T., Momoi M., Murai K., Ikematsu K., Suwa K., Sakamoto K., Fujimura A. Penipenem-betamipron and decreases in serum valproic acid concentration. Ther. Drug. Monit. 1998; 20: 396–400
- Yamamura N., Imura-Miyoshi K., Naganuma H., Nishimura K. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats. Drug Metab. Dispos. 1999; 27: 724–730
- Yamamura N., Imura-Miyoshi K., Naganuma H. Panipenem, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats. Drug. Metab. Dispos. 2000; 28: 1484–1486
- Yokogawa K., Iwashita S., Kubota A., Sasaki Y., Ishizaki J., Kawahara M., Matsushita R., Kimura K., Ichimura F., Miyamoto K. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits. Pharm. Res. 2001; 18: 1320–1326